Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Active versus Passive Immunity01:31

Active versus Passive Immunity

Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased Gene Therapy Efficacy Through the Use of Extended Half-Life Clotting Factors.

Blood advances·2026
Same author

Matchmaking gene therapy with mimetic antibodies.

Blood·2025
Same author

CRISPR and gene editing technologies for bleeding disorders.

Therapeutic advances in hematology·2025
Same author

Long-Term Functional Correction of Pompe Disease and Increased α-Glucosidase Expression after Gene Therapy with Novel Combinations of Muscle-Targeted Transcriptional <i>Cis</i>-Regulatory Elements.

Human gene therapy·2025
Same author

Comprehensive analysis of off-target and on-target effects resulting from liver-directed CRISPR-Cas9-mediated gene targeting with AAV vectors.

Molecular therapy. Methods & clinical development·2024
Same author

Treatment of infantile-onset Pompe disease in a rat model with muscle-directed AAV gene therapy.

Molecular metabolism·2024

Related Experiment Video

Updated: Jun 20, 2026

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
08:32

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production

Published on: March 2, 2014

Muscling through AAV immunity.

Thierry VandenDriessche1

  • 1University of Leuven.

Blood
|September 5, 2009
PubMed
Summary

Adeno-associated virus serotype 1 (AAV-1) is a promising gene therapy vector for skeletal muscle. However, AAV-1 gene transfer into human skeletal muscle activates capsid-specific T cells, a crucial consideration for clinical applications.

Area of Science:

  • Gene therapy
  • Immunology
  • Muscle biology

Background:

  • Adeno-associated virus serotype 1 (AAV-1) shows potential for skeletal muscle gene delivery.
  • Understanding immune responses to viral vectors is critical for safe gene therapy.

Discussion:

  • This study investigates the immune response to AAV-1 in human skeletal muscle.
  • Mingozzi and colleagues demonstrate T cell activation following AAV-1 gene transfer.

Key Insights:

  • AAV-1 gene transfer into human skeletal muscle elicits a capsid-specific T cell response.
  • This finding highlights potential immunogenicity concerns for AAV-1 in muscle gene therapy.

Outlook:

  • Further research is needed to assess the long-term implications of T cell activation.

Related Experiment Videos

Last Updated: Jun 20, 2026

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
08:32

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production

Published on: March 2, 2014

  • Strategies to mitigate immune responses may be necessary for optimizing AAV-1 gene therapy efficacy and safety in skeletal muscle.